|
|
||||||||
J Thorac Cardiovasc Surg 2008;136:1510-1513
© 2008 The American Association for Thoracic Surgery
Acquired Cardiovascular Disease |
Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Mass
Received for publication December 16, 2007; revisions received February 26, 2008; accepted for publication March 7, 2008. * Address for reprints: Minoru Tabata, MD, MPH, Division of Cardiothoracic Surgery, Columbia University, College of Physicians and Surgeons, 177 Fort Washington Avenue, MHB 7-435, New York, NY 10032. (Email: mtabata{at}post.harvard.edu).
Objective: 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to have pleiotropic effects in addition to their lipid-lowering properties. Some studies have shown the beneficial effect of preoperative statins on operative outcomes in coronary artery bypass grafting. However, the effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery remains poorly defined.
Methods: We performed a retrospective review of 1389 consecutive patients undergoing cardiac valve surgery between January of 2002 and December of 2005. Patients undergoing concomitant coronary artery bypass surgery and those with a history of myocardial infarction and coronary interventions were excluded. Of this cohort, 363 patients were receiving a statin preoperatively and 1026 patients were not. Propensity scores were constructed with patients' demographics, clinical data, and the year of procedure. Generalized estimating equations, including the propensity score as a covariate, were used to investigate whether preoperative statin use is associated with improved operative outcomes.
Results: The crude operative mortality rate was 0.8% and 2.3%, the incidence of stroke was 1.7% and 2.9%, and the incidence of perioperative myocardial infarction was 2.2% and 2.4% in the statin and non-statin groups, respectively. Generalized estimating equations showed that preoperative statin use is associated with lower mortality (odds ratio: 0.25, 95% confidential interval: 0.12–0.54). Preoperative statin use was not significantly associated with an incidence of stroke (odds ratio: 0.48, 95% confidential interval: 0.19–1.22) or perioperative myocardial infarction (odds ratio: 0.91, 95% confidential interval: 0.43–1.91) in this cohort.
Conclusion: Preoperative use of statins may improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery.
Related Article
This article has been cited by other articles:
![]() |
M. Tabata Reply to the Editor J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 792 - 792. [Full Text] [PDF] |
||||
![]() |
H. Takagi and T. Umemoto A meta-analysis of controlled studies of preoperative statin therapy for prevention of postoperative mortality in cardiac surgery J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 790 - 791. [Full Text] [PDF] |
||||
![]() |
L. Mascitelli, F. Pezzetta, and M. R. Goldstein Does hypercholesterolemia improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery? J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 256 - 256. [Full Text] [PDF] |
||||
![]() |
M. Tabata Reply to the Editor J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 256 - 257. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |